| Morning Session |
| 9:00 | Welcome and Introduction |
| Aymeric Sallin, NanoDimension |
| 9:05 | Introduction to Nanotechnology |
| Aymeric Sallin, NanoDimension |
| 9:20 | Nanotechnology: the next disruptive technology? Lessons from the past |
| Dr. Sassan Zaker, First Vice President, Bank Julius Bär |
| 9:45 | Investing in Nanotechnology: public and private investment opportunities |
| Dr. Alexandre Gauthier-Jaques, Director, UBS Wealth Management |
| |
| 10:10 | Coffee Break |
| |
| 10:30 | Nanotechnology going public: a compelling choice |
| Stefan Höfer, Stock Market Business Development, Deutsche Börse |
| 10:55 | Trade sale of nanotechnology companies — trends and opportunities |
| Dr. Tapesh Yadav, Founder, Nanoproducts Corporation |
| 11:20 | Panel Discussion: Investing in Nanotechnology |
|
|
| 12:15 | Lunch |
| Afternoon Session |
| 13:40 | Business Models for Nanotech Companies |
| Aymeric Sallin, NanoDimension |
| 13:55 | Oxonica: a leading European nanomaterial company |
| Christopher Moore, Chairman, Oxonica |
| 14:20 | Flisom AG: an emergent Swiss solar cell manufacturer |
| Ayodhya Tiwari, Chairman & CTO, Flisom AG |
| 14:45 |
Crocus Technology SA: developing next generation memory type — MRAM |
| Jean-Pierre Braun, CEO, Crocus Technologies SA |
| 15:10 |
MagForce’s Nano Cancer Therapy - a Revolutionary Approach |
| Andreas Jordan, CEO, MagForce Nanotechnologies AG |
| |
| 15:35 | Coffee Break |
| |
| 15:55 | Risks of Nanotechnology from an environmental and health perspective |
| Del Stark, CEO, The European Nanotechnology Trade Alliance (ENTA) |
| 16:20 | Panel discussion: Risks of Nanotechnology |
|
- Lucas Frei, Casualty Manager, Allianz Global Corporate & Specialty
- Dr. Antje Grobe, Head of Division Nanotechnology, Stiftung Risiko-Dialog
- Michael Kuprianczyk, Head D&O Underwriting, Allianz Global Corporate & Specialty
- Del Stark, CEO, The European Nanotechnology Trade Alliance (ENTA)
- Dr. Tapesh Yadav, Founder, NanoProducts Corporation
|
| 17:00 | End |
